https://www.selleckchem.com/pr....oducts/Raltitrexed.h
ing. To assess the burden of rare genetic variants and to estimate the contribution of known ALS genes in an Italian population-based cohort we performed whole genome sequencing in 959 ALS patients and 677 matched healthy controls. We performed genome sequencing in a population-based cohort (Piemonte and Valle d'Aosta Registry for ALS, PARALS). A panel of 40 ALS genes was analyzed to identify potential disease-causing genetic variants and to evaluate the gene-wide burden of rare variants among our population. A total of 959 ALS pati
Like
Comment
Share
